Rinaldi et al. [61], who explored a set of 11,616 breast tumors, including 5034 non-paired metastases, showed a significant enrichment for ESR1 mutations in metastasis (18.3% in metastases vs. 2.2% in local disease). This evidence concerns the gene ESR1 and breast neoplasm.